Biomarin Pharmaceutical (BMRN) Amortization - Intangibles (2023 - 2026)
Biomarin Pharmaceutical's Amortization - Intangibles came in at $73.49 million for Q2 2026, compared with $4.85 million a year earlier.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Amortization - Intangibles (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Biomarin Pharmaceutical reported Amortization - Intangibles of $87.67 million, up 260.0% year-over-year; for FY2025, it was $19.39 million, down 55.2% from FY2024.
- Amortization - Intangibles has declined in each of the last three years, with a three-year compound annual growth rate of -33.9% (FY2022 to FY2025).
- Going back by year, Amortization - Intangibles was $43.26 million in FY2024 (-30.5%), $62.21 million in FY2023 (-7.4%) and $67.19 million in FY2022.
- The Q2 2026 figure represents the highest quarterly Amortization - Intangibles in data going back to Q1 2023.
- Over the past five years, the year-over-year decline in Amortization - Intangibles ranged from 3.2% (Q3 2025) to 68.1% (Q3 2024).
- Business Quant data shows BMRN's Amortization - Intangibles at $4.48 million (Q1 2026), $4.85 million (Q4 2025) and $4.85 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Biomarin Pharmaceutical | 11.61 Bn | 5.48 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 73.49 Mn |
| Mar 31, 2026 | 4.48 Mn |
| Dec 31, 2025 | 4.85 Mn |
| Sep 30, 2025 | 4.85 Mn |
| Jun 30, 2025 | 4.85 Mn |
| Mar 31, 2025 | 4.85 Mn |
| Dec 31, 2024 | 9.65 Mn |
| Sep 30, 2024 | 5.01 Mn |
| Jun 30, 2024 | 14.30 Mn |
| Mar 31, 2024 | 14.30 Mn |
| Dec 31, 2023 | 15.24 Mn |
| Sep 30, 2023 | 15.68 Mn |
| Jun 30, 2023 | 15.62 Mn |
| Mar 31, 2023 | 15.67 Mn |
API Access
Biomarin Pharmaceutical Amortization - Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "amortization-intangibles", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=amortization-intangibles&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();